109 / 144
109
Ophthalmol. 2017; 27:357-362.
21. Habiba S, Astha A, Yit Y. Clinical utility of intravitreal `uocinolone acetonide implant
in the management of patients with chronic diabetic macular edema: a review of the
current literature. Clinical Ophthalmology. 2017;11:583-590.
22. Meireles A, Goldsmith C, El-Ghrably I, et al. Ef%cacy of 0.2μg/day `uocinolone aceto-
nide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy. Eye.
2017 May;31(5):684-690. Doi: 10.1038/eye.2016.303. Epub 2017 Jan 13
23. Phase II combination steroid and anti-VEGF for persistent diabetic macular edema. Cli-
nical Trials.gov.
24. Combination Ozurdex and Lucentis vs Ozurdex monotheraphy in incomplete respon-
ders with diabetic macular edema (COLLIDE). Clinical Trials.gov.
25. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy
Study report number 1. Early Treatment Diabetic Retinopathy Study research group.
Arch Ophthalmol.1985;103:1796-1806.
26. Romero-Aroca P. Is Laser Photocoagulation Treatment Currently Useful in Diabetic
Macular Edema? Med Hypothesis Discov Innov Ophthalmol. 2015; 4: 5-8.
27. Haller J.A, Qin H, Apte S. Diabetic Retinopathy Clinical Research Network Writing
Committee. Vitrectomy outcomes in eyes with diabetic macular edema and vitreoma-
cular traction. Ophthalmology. 2010;117:1087-1093.
28. Simunovic M, Hunyor A, Ho I. Vitrectomy for diabetic macular edema: a systematic
review and meta-analysis. Can J Ophthalmol. 2014; 49: 188-195.